Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Unilateral U/S PVB 1 Stomach Neoplasms 1 Pain, Postoperative 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Epstein-Barr Virus Infections 1 Diarrhea 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

spartalizumab 1 ruxolitinib 1 dolutegravir 1 Rituximab 1 Ritonavir 1 Nucleosides 1 Dexamethasone 1 Darunavir 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Epstein-Barr Virus Infections × Control Groups × Clear all

NCT04989491 2024-08-19

REPLY

University Hospital, Strasbourg, France

Phase 4 Recruiting

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡